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The deubiquitinating module (DUBm) of the SAGA
coactivator contains the Ubp8 isopeptidase, Sgf11,
Sus1, and Sgf73, which form a highly interconnected
complex. Although Ubp8 contains a canonical USP
catalytic domain, it is only active when in complex
with the other DUBm subunits. The Sgf11 zinc finger
(Sgf11-ZnF) binds near the Ubp8 active site and is
essential for full activity, suggesting that the Sgf11-
ZnF helps maintain the active conformation of
Ubp8. We report structural and solution studies
showing that deletion of the Sgf11-ZnF destabilizes
incorporation of Ubp8 within the DUBm, giving rise
to domain swappingwith a second complex andmis-
aligning active site residues. Activating mutations in
Ubp8 that partially restore activity in the absence
of the Sgf11-ZnF promote the monomeric form of
the DUBm. Our data suggest an unexpected role
for Sgf11 in compensating for the absence of struc-
tural features that maintain the active conformation
of Ubp8.
INTRODUCTION
The SAGA (Spt-Ada-Gcn5-acetyltransferase) transcriptional
coactivator is a 1.8 MDa, 21-protein complex that regulates
inducible yeast genes by performing multiple functions including
acetylating core histones, recruiting the RNA polymerase II pre-
initiation complex, and deubiquitinating histone H2B (reviewed in
Baker and Grant, 2007; Koutelou et al., 2010; Rodrı´guez-
Navarro, 2009). At genes activated by SAGA, the E2 ubiquitin
conjugating enzyme, Rad6, and the E3 ubiquitin ligase, Bre1,
mono-ubiquitinate histone H2B at Lys123 (Hwang et al., 2003).
This modification promotes recruitment of Set1, which methyl-
ates histone H3 at Lys4 and triggers the recruitment of the
SAGA complex (Daniel et al., 2004). SAGA acetylates histone
H3 and deubiquitinates histone H2B (H2B-Ub), which is required
for downstream events including phosphorylation of the
C-terminal domain (CTD) of RNA polymerase II by Ctk1 and1414 Structure 20, 1414–1424, August 8, 2012 ª2012 Elsevier Ltd Almethylation of H3K36 by Set2 (Weake and Workman, 2010;
Wyce et al., 2007). Mutations and deletions that abrogate the
deubiquitinating activity of SAGAgive rise to defects in both tran-
scription activation and elongation (Daniel et al., 2004; Wyce
et al., 2007; Henry et al., 2003), pointing to a key role for deubi-
quitination in the transcription of inducible genes. The deubiqui-
tinating activity of SAGA resides in a distinct subcomplex called
the deubiquitinating module (DUBm), which consists of four
proteins that are conserved across eukaryotes: Ubp8, Sgf11,
Sus1, and Sgf73, of which residues 1–96 are sufficient for
in vitro DUBm activity (Ko¨hler et al., 2008). The enzymatic sub-
unit, Ubp8, contains a C-terminal catalytic domain belonging
to the ubiquitin-specific protease (USP) family of deubiquitinat-
ing enzymes (DUBs) (Reyes-Turcu and Wilkinson, 2009; Henry
et al., 2003) and an N-terminal ZnF-UBP domain (Henry et al.,
2003; Ingvarsdottir et al., 2005; Reyes-Turcu et al., 2006) that
is required for incorporation into the SAGA complex (Ingvarsdot-
tir et al., 2005). USP enzymes are papain-like cysteine proteases
that contain a conserved Cys-His catalytic dyad as well as
conserved oxyanion hole residues that are required for a
conserved general mechanism of deubiquitination (Zhang
et al., 2011; Komander et al., 2009; Hu et al., 2002). Although
Ubp8 contains a canonical USP domain, this subunit is inactive
unless it is in complex with the other three DUBm subunits (Ko¨h-
ler et al., 2008; Lee et al., 2009). Relatively small deletions in
Sgf11 and Sgf73 disrupt DUBm activity (Ko¨hler et al., 2008,
2010), pointing to the important role these proteins play in
contributing to enzymatic activity.
The structure of the DUBm revealed an unexpected arrange-
ment of Ubp8, Sgf11, Sus1, Sgf73, in which each protein
contacts the other three to form a highly interconnected complex
(Samara et al., 2010; Ko¨hler et al., 2010). The DUBm proteins are
organized into two lobes around the globular domains of Ubp8
(Figure 1A). The ZnF-UBP (Samara et al., 2010), or assembly
lobe (Ko¨hler et al., 2010) of the complex is centered around the
long N-terminal helix of Sgf11, which has one face that binds
to the ZnF-UBP domain of Ubp8, whereas the other face binds
Sus1 (Samara et al., 2010; Ko¨hler et al., 2010). An extended
ordered linker joins the Sgf11 N-terminal helix to its C-terminal
zinc finger domain (Sgf11-ZnF), which binds to the Ubp8 USP
domain immediately adjacent to the catalytic site (Figures 1A
and 1B). The Sgf11-ZnF makes extensive contacts with a loop
(referred to as loop L2) that contains active site residues, inl rights reserved
Figure 1. Gain-of-Function Mutations in Ubp8 that Compensate for Deletion of the Sgf11 Zinc Finger
(A) Structure of the wild-type DUBm. The four subunits are Ubp8 (green), Sgf11 (orange), Sus1 (blue), Sgf73 (salmon); zinc atoms are depicted as red spheres. The
USP and ZnF-UBP domains of Ubp8 are indicated. The Sgf11-ZnF (in dotted circle) binds to the USP domain of Ubp8 and is connected to its helical region by an
extended linker.
(B) The Sgf11-ZnF (orange) binds near the Ubp8 (green) active site, contacting loops L1 and L2. The catalytic residues, C146 and H427, and the oxyanion hole
residue, N141 are depicted as sticks. Loop L1 (dashed green line) is disordered in the absence of bound ubiquitin.
(C) Rate of Ub-AMC cleavage as a function of substrate concentration by wild-type DUBm and DUBm lacking the Sgf11-ZnF and containing either wild-type or
Ubp8 with substitutions S144N, S149N, or S144N/S149. The average of three initial rate measurements were plotted with error bars corresponding to SD.
(D) Sequence alignment of USP DUBs indicating residues 144 and 149 of Ubp8. Diagram in green below sequence indicates secondary structure in Ubp8.
(E) Superposition of Ubp8 (green) with hUSP8 (pink) showing hydrogen bonding between the asparagine aligned with Ubp8(S149) in hUSP8 with loop L2
backbone residues. Residue S149 in Ubp8 does not contact loop L2. The asparagine in hUSP8 that is aligned with S144 in Ubp8 contacts the carboxyl oxygen of
a conserved tyrosine in loop L1.
(F) Cleavage of K48-diubiquitin by wild-type and mutant DUBm. Gel stained with Coomassie.
See also Figure S2.
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Role of Sgf11 in Stabilizing the SAGA DUB Moduleaddition to connecting the USP domain of Ubp8 to its ZnF-UBP
domain. Sgf731–96, which has a low degree of secondary struc-
ture and contains a C-terminal zinc finger, is partially buried
between the two lobes of the DUB module and makes extensive
contacts with both domains of Ubp8 (Figure 1A). The zinc fingers
of Sgf11 and Sgf73 are critical for DUB module activity: deletion
of the Sgf11-ZnF drastically reduces enzymatic activity, whereas
deletion of the Sgf73 zinc finger causes Sgf73 to dissociate from
the DUB module, thus abrogating activity (Ko¨hler et al., 2008,
2010). The dependence of Ubp8 deubiquitinating activity on
the presence of additional subunits is not unique; USP1,
USP12, and USP46 all require the regulatory protein UAF1 for
activity (Kee et al., 2010; Cohn et al., 2007, 2009), and the H2A
DUB, BAP1, requires ASX for activity (Scheuermann et al.,
2010). The mechanism by which these DUBs are regulated by
additional subunits is not known.
A potential model for how Sgf11-ZnF activates Ubp8 was
suggested by structural studies of HAUSP/Usp7 (Hu et al.,
2002; Faesen et al., 2011) and OTUB1 (Edelmann et al., 2009;
Wiener et al., 2012). In those deubiquitinating enzymes, the
active site residues are misaligned in the absence of ubiquitin
and become correctly aligned when the ubiquitin substrate is
bound (Edelmann et al., 2009; Wiener et al., 2012; Hu et al.,
2002). Unlike HAUSP and OTUB1, the active site residues of
Ubp8 are aligned for catalysis in both the absence and presenceStructure 20, 1414of ubiquitin (Samara et al., 2010; Ko¨hler et al., 2010). One way in
which the other DUBm subunits could activate Ubp8 would be
by maintaining the correct conformation of the Ubp8 active
site. The Sgf11-ZnF makes extensive hydrogen bonding interac-
tions with loop L2 in Ubp8, which contains the catalytic cysteine,
C146, and the oxyanion hole residue, N141 (Figure 1B). Sgf11
also contacts active site loop L1 (Figure 1B), which contains resi-
dues (aa 235–237) that interact with the C-terminal tail of ubiqui-
tin but is disordered in the absence of bound ubiquitin (Samara
et al., 2010). These important interactions, coupled with the
observation that deletion of the Sgf11-ZnF significantly reduces
DUBm activity (Ko¨hler et al., 2010), raised the possibility that the
Sgf11-ZnF may directly affect enzymatic activity by helping to
orient the active site residues in the proper conformation for
catalysis.
We report here structural and solution studies aimed at deter-
mining the role that Sgf11 plays in activating Ubp8 within the
DUBm. Based on comparisons with USP enzymes that do not
require partner proteins for activity, we introduced gain-of-
function mutations into Ubp8 that were designed to stabilize
the structure of the active site and thus overcome the deleterious
effect of deleting the Sgf11-ZnF. We were able to identify two
substitutions in Ubp8 that partially restored DUBm activity in
the absence of the Sgf11-ZnF. However, crystal structures
of the DUBm lacking the Sgf11-ZnF and containing either–1424, August 8, 2012 ª2012 Elsevier Ltd All rights reserved 1415
Table 1. Kinetic Constants for Wild-type and Mutant DUBm
Cleavage of Ub-AMC
DUB Module
Mutant kcat (s
1) KM (mM)
kcat/KM
Critical c2(M1 s1)
WT 4.4 ± 0.3 24 ± 2 (1.8 ± 0.2) 3 105 3.1 3 102
S144N 6.5 ± 0.3 28 ± 2 (2.3 ± 0.2) 3 105 2.0 3 102
S149N 3.1 ± 0.2 20 ± 2 (1.6 ± 0.2) 3 105 2.2 3 102
DZnF 0.063 ± 0.01 19 ± 1 (3.3 ± 0.4) 3 103 3.1 3 105
DZnF S144N 0.28 ± 0.02 17 ± 2 (1.6 ± 0.2) 3 104 4.5 3 104
DZnF S149N 0.26 ± 0.02 11 ± 1 (2.4 ± 0.3) 3 104 5.9 3 104
DZnF S144N
S149N
0.47 ± 0.02 13 ± 1 (3.6 ± 0.3) 3 104 1.1 3 103
See also Figure S1.
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Role of Sgf11 in Stabilizing the SAGA DUB Modulewild-type or mutant Ubp8 revealed an unanticipated role for
the Sgf11-ZnF in maintaining the structural integrity of the DUB
module, which in turn is important for Ubp8 activation. We find
that deleting the Sgf11-ZnF destabilizes the compact folding
of the DUBm by disrupting its interactions with Ubp8 loop L2,
which joins the USP and ZnF-UBP domains. In the absence of
contact with the Sgf11-ZnF, this loop adopts an extended con-
formation that permits the Ubp8 ZnF-UBP domain to peel
away from the remainder of the DUBm and participate in
domain-swapping interactions with another DUBm. In the result-
ing domain-swapped DUBm dimer, some of the active site resi-
dues in Ubp8 are misaligned. Analytical ultracentrifugation
studies show that one of the mutations that restore DUBm
activity in the absence of Sgf11 stabilizes the monomeric,
compact conformation of Ubp8, which in turn ensures the
correct configuration of the active site. The second activating
mutation only partially shifts the equilibrium toward themonomer
and may play an additional role in organizing the active site.
These results suggest an unanticipatedmechanism formaintain-
ing Ubp8 in an active state, whereby Sgf11 promotes the proper
organization of the DUBm and compensates for the intrinsic flex-
ibility of a key portion of Ubp8.
RESULTS
Gain of Function Mutations in Ubp8 Partially
Compensate for Deletion of the Sgf11 Zinc Finger
Deletion of the Sgf11-ZnF significantly reduces DUBm activity
(Figure 1C) (Ko¨hler et al., 2010), with >50-fold reduction in kcat/KM
(Table 1). Because the Sgf11-ZnF contacts Ubp8 loop L1, which
contacts the substrate ubiquitin, and loop L2, which contains
catalytic residues (Figure 1B), we speculated that the decrease
in Ubp8 enzymatic activity was due to the loss of stabilizing
contacts between loops L1 and L2 and the Sgf11-ZnF. Using
structural and sequence alignments with other USP enzymes
that do not depend upon partner proteins for activity, we
searched for residues that are conserved in the active site loops
of other USP DUBs (Avvakumov et al., 2006; Hu et al., 2002,
2005; Renatus et al., 2006; Ye et al., 2011), but not in Ubp8,
and could potentially account for the dependence of Ubp8
activity on Sgf11. The alignments revealed two serine residues
in Ubp8, S144, and S149 that are typically asparagine in other
USP DUBs (Figure 1D). Ubp8 residue S144, which is part of1416 Structure 20, 1414–1424, August 8, 2012 ª2012 Elsevier Ltd Alactive site loop L2, is found in place of a conserved asparagine
residue in hUSP8 that donates a hydrogen bond to the backbone
carbonyl of Y864 on loop L1 of hUSP8 (Avvakumov et al., 2006).
A similar interaction is found in other USP DUBs such as hUSP2,
hUSP21, and hUSP14 (Hu et al., 2005; Renatus et al., 2006; Ye
et al., 2011). Model building with the structure of the SAGA
DUBm showed that substituting an asparagine for S144 in
Ubp8 could give rise to an analogous hydrogen bond with the
backbone carbonyl of the conserved tyrosine in Ubp8, Y233
(Figure 1E). Similarly, replacement of S149 in Ubp8 with an
asparagine could potentially donate two hydrogen bonds to
the backbone carbonyl groups of residues L139 and I140 in
loop L2, which could stabilize loop L2 in the absence of the
Sgf11-ZnF and thus potentially maintain enzymatic activity of
the DUBm (Figure 1E).
To test whether the presence of serine rather than asparagine
at positions 144 and 149 was responsible for the dependence of
Ubp8 activity on the Sgf11-ZnF, we asked whether S144N or
S149N substitutions in Ubp8 could overcome the deleterious
effects of an Sgf11-ZnF deletion. We introduced the single muta-
tions, as well as the double mutation, into Ubp8 and purified
DUBm complexes containing the mutated Ubp8 proteins, the
truncated Sgf111–72 fragment lacking the C-terminal zinc finger
(Sgf11-DZnF) and wild-type Sgf11 and Sus1. In cleavage assays
using ubiquitin-AMC (Ub-AMC) as the substrate, we found that
the S144N or S149N mutation in Ubp8 increases the activity of
the SAGA DUBm in the absence of Sgf11-ZnF by 5- or 7-fold,
respectively (Figure 1F and Table 1). The double substitution
Ubp8S144NS149N has an additive effect on DUBm activity in
Ub-AMC cleavage assays, increasing kcat/KM 11-fold (Figure 1F
and Table 1). Notably, the Sgf11-ZnF deletion and the activating
mutations largely affect kcat, with KM values differing by <2-fold
among all complexes tested, indicating that the mutations and
deletions primarily affect catalysis and not substrate binding
(Table 1). The Ubp8 S144N and S149N substitutions do not
increase activity in the context of DUBm containing intact
Sgf11 (Table 1), indicating that these substitutions do not simply
increase the intrinsic activity of Ubp8. To verify that the observed
effects of the stabilizing mutations were not substrate-specific,
DUBm activity was assayed using K48-linked diubiquitin, which
can also be cleaved by the DUBm. The overall effect of themuta-
tions on cleavage of K48-linked diubiquitin (Figure 1G) is similar
to that observed in Ub-AMC assays (Figure 2D). These data are
consistent with the hypothesis that Sgf11 compensates for the
absence of conserved residues that are important for maintain-
ing an active conformation of Ubp8.
Deletion of the Sgf11 Zinc Finger Results in a Domain-
Swapped DUB Module Dimer
To gain insight into the role of Sgf11 in maintaining the active
conformation of Ubp8, we determined structures of the DUBm
lacking the zinc finger of Sgf11, and containing either wild-type
Ubp8 or the activating mutant Ubp8S144N. Both complexes
crystallize in space group P212121 with two complexes in
the asymmetric unit that are related by a noncrystallographic
2-fold axis. The structures of DUBm-DSgf11-ZnF-Ubp8WT and
DUBm-DSgf11-ZnF-Ubp8S144N were determined by molecular
replacement using as a search model the coordinates of the
DUBm (PDB ID: 3MHS) (Samara et al., 2010), and refined tol rights reserved
Figure 2. Structure of DUBm Lacking the Sgf11-ZnF Shows Domain Swapping
(A) Structure of DUBm-DSgf11-ZnF/Ubp8-S144N shows domain swapping between two DUBm complexes. The two Ubp8 subunits in the complex are colored
green and purple, respectively. Other subunits colored as indicated: Sus1 (blue), Sgf11 (orange), Sgf73 (salmon). The disordered Sgf11 linker is represented by a
dashed orange line.
(B) Initial fit of twoDUBmcomplexes to the electron densitymapbefore detection of domain swapping (2Fo-Fc contoured at 1s, gray, Fo-Fc contoured at 3s, red).
(C) Fit of domain-swapped complexes to 2Fo-Fc electron density map.
(D) Conformation of Ubp8 in wild-type, intact DUBm (gray) and in domain-swapped complex (green). Residues 133–145 in loop L2 undergo a major confor-
mational change that accompanies domain swapping.
(E) Helix in Ubp8 that is buried by the Sgf11-ZnF in the intact DUBm mediates dimerization contacts in the domain-swapped DUBm-DSgf11-ZnF.
Structure
Role of Sgf11 in Stabilizing the SAGA DUB Module2.8 A˚ and 2.7 A˚ resolution, respectively. Data and refinement
statistics are given in Table 2.
Although the overall architecture of each complex appears
similar to that of the WT DUBm, we unexpectedly found that
the two complexes participate in domain swapping interactions,
with the N-terminal ZnF-UBP domain incorporated into one
DUBmwhereas the USP domain is incorporated into the second
complex (Figure 2A). The domain swapping was initially noted in
electron density maps by the absence of density for loop L2
residue G143 and the presence of unaccounted-for density
bridging the two complexes (Figures 2B and 2C). The domain
swapping is the result of a dramatic conformational change in
loop L2 residues 133–145, which peel away from the USP
domain and bridge the junction between opposing complexes
(Figure 2D). The repositioned Ubp8 ZnF-UBP domain is related
to its position in the wild-type structure by a 180 rotation (Fig-
ure 2D). Only one of the cross-over loops is ordered in the
DUBm-DSgf11-ZnF complex containing wild-type Ubp8,
whereas both loops are ordered in the DUBm-DSgf11-ZnF-
Ubp8S144N complex (Figures 3A and 3B). With the exception of
themarked changes in the residues connecting the two domainsStructure 20, 1414of Ubp8, the wild-type DUBm superposes with each domain-
swapped complex with a root-mean-square deviation (rmsd) of
1.3 A˚. In addition to the tethering of the two complexes via
the loop L2 residues, the two Ubp8 USP domains contact one
another with a helix (residues 214–226) that is partially buried
by the Sgf11-ZnF in the intact DUBm (Figure 2E).
The extended linker (residues 46–72) that connects the
N-terminal helix of Sgf11 to its zinc finger in the wild-type
complex (Figure 1A) is disordered in the DZnF structures, indi-
cating that the zinc finger is required to anchor the flexible linker
to the surface of the USP domain of Ubp8 (Figure 2A). Loop L1 of
Ubp8, which is disordered in the intact apo DUBm complex
(Samara et al., 2010; Ko¨hler et al., 2010), and becomes ordered
upon contacting the C-terminal tail of ubiquitin (Samara et al.,
2010), is unexpectedly well-ordered in both molecules in the
DUBm-DSgf11-ZnF complex. The ordering of loop L1 appears
to be due to stabilizing contacts with S144 in loop L2, which
are made possible by the conformational change in loop L2
(Figure 3A). Loop L1 is ordered in just one molecule of the
DUBm-DSgf11-ZnF-Ubp8S144N complex as a result of hydro-
gen bonding interactions with N144 in the opposing loop L2–1424, August 8, 2012 ª2012 Elsevier Ltd All rights reserved 1417
Table 2. X-Ray Crystallographic Data and Refinement Statistics
Data Collection
Statistics
DUBm-DSgf11-
ZnF-Ubp8WT
DUBm-DSgf11-
ZnF-Ubp8S144N
DUBm-
Ubp8S144N
Energy (eV) 12,000 12,000 12,658
Resolution limit (A) 2.85 2.69 2.03
Unique reflections 38,364 43,595 61,049
Redundancy 10.9 (6.0) 7.8 (6.2) 14.8 (14.8)
Completeness (%) 97.6 (94.7) 91.9 (84.9) 100 (100)
Average I/s (I) 10.8 (1.2) 12.2 (2.3) 28.8 (4.73)
Rsym (%) 21.7 (93.0) 15.1 (63.7) 9.7 (86.5)
Refinement statistics
Space group
and unit cell (A˚)
P212121
a = 76.5
b = 79.2
c = 265.9
P212121
a = 75.9
b = 80.0
c = 274
P212121
a = 83.6
b = 105
c = 107
Molecules per
asymmetric unit
1 1 1
Rwork (%) 20.0 18.3 17.7
Rfree (%) 27.6 26.4 21.2
Rmsd bonds (A˚) 0.011 0.012 0.020
Rmsd angles (o) 1.436 1.545 1.277
Protein atoms 10,528 10,637 5,719
Water molecules 46 92 398
Zinc (II) ions 14 14 8
Average B (A˚2) 41.5 44.5 31.3
Rmsd, root-mean-square deviation.
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Role of Sgf11 in Stabilizing the SAGA DUB Module(Figure 3B). The N144 residue in the second Ubp8 protein adopts
a different conformation and forms hydrogen bonds that bridge
the L2 loops of the two opposing Ubp8 proteins (Figure 3B). In
the absence of contacts with N144, loop L1 of the second
Ubp8 molecule becomes disordered (Figure 3B).
The structures show that the dramatic alteration of the loop L2
conformation that accompanies domain swapping changes the
alignment of active site residues, potentially accounting for the
loss of activity in these versions of the DUBm. The predicted
oxyanion hole residue, N141, is located in loop L2 and is thus
repositioned as a result of domain swapping (Figures 4A–4D).
As a consequence, N141 fromoneUbp8molecule is either incor-
rectly positioned in the active site of the second Ubp8 molecule
relative to its position in the wild-type DUBm or disordered1418 Structure 20, 1414–1424, August 8, 2012 ª2012 Elsevier Ltd Al(Figures 4A–4D). In either case, the residue is not in an orientation
to interact with the oxyanion intermediate that forms during
catalysis.
To confirm that the repositioning of loop L2 and misalignment
of N141 occurs because of the absence of the Sgf11-ZnF and
not because of the S144Nmutation, we determined the structure
of DUBm-apo with full-length Sgf11 and Ubp8S144N to 2.0 A˚
resolution (Table 2). The structure of the DUBm containing
Ubp8 S144N is virtually identical to that of the wild-type apo
DUBm structure, including the active site conformation and the
disorder of loop L1 (Figure S2 available online).
The DUBm-Sgf11(DZnF)-Ubp8WT and DUBm-
Sgf11(DZnF)-Ubp8S144N Complexes Are Dimers
in Solution
To test whether the domain-swapped dimerization of the
DUBm occurs in solution, we used analytical ultracentrifugation
to assess the dimerization state of the Sgf11-ZnF deletion
mutants. Sedimentation velocity (Figure 5) and equilibrium sedi-
mentation (Figure S3) experiments show that the intact DUBm
behaves as a monomer (Figure 5A), whereas DUBm lacking
the Sgf11-ZnF (DUBm-DSgf11-ZnF-Ubp8WT) exists in a mono-
mer-dimer equilibrium (Figure 5B) with a Kd 17 mM (Figure S3;
Tables S1 and S2). The proportion of monomer is somewhat
higher when Ubp8 contains the S144N substitution (Figure 5C),
with a Kd for the monomer-dimer equilibrium of 28 mM (Fig-
ure S3; Tables S1 and S2). By contrast, the S149N substitution
alone and the double S144N/S149N substitution in Ubp8
restore the monomeric behavior of DUBm complexes lacking
the Sgf11 zinc finger: DUBm-DSgf11-ZnF-Ubp8S149N and
DUBm-DSgf11-ZnF-Ubp8S144N/S149N (Figures 5D, 5E, 5F, and
S3). The monomeric states adopted by the DUBm lacking the
Sgf11-ZnF have a molecular weight and sedimentation co-
efficient similar to the monomeric wild-type DUBm, suggesting
that their shape is similar to that of the intact wild-type DUBm in
solution. Overall, the analytical ultracentrifugation studies show
that the domain-swapped dimer that is observed in the crystal
forms in solution and is in equilibrium with monomeric DUBm.
Taken together, our results indicate that deletion of the
Sgf11-ZnF destabilizes the association of the Ubp8 catalytic
domain with the remainder of the DUBm, thus disrupting
enzymatic activity, and that activating mutations in Ubp8
partially restore activity by stabilizing the properly folded, mono-
meric DUBm.Figure 3. Ubp8 Loops L1 and L2 in the Domain-
Swapped Structures
(A) Detailed view of Ubp8 crossover loops (L2) and loop L1
in the domain-swapped DUBmDSgf11-ZnF-Ubp8WT
structure. Respective Ubp8 monomers are colored purple
and green.
(B) View as in (A) of the DUBm-DSgf11-ZnF-Ubp8S144N
complex.
See also Tables S1 and S2.
l rights reserved
Figure 4. Effect of Domain Swapping on the Oxyanion Hole
Residue, N141
(A) Superposition of one Ubp8 monomer in the domain-swapped DUBm
complex lacking the Sgf11-ZnF (green) with Ubp8 in intact DUBm complex
(gray) showing altered position of N141.
(B) Superposition as in (A) showing the second Ubp8 monomer (purple) in the
domain-swapped complex in which N141 disordered.
(C and D) Superpositions as in (A) showing Ubp8 in the domain-swapped
DUBm-DSgf11-ZnF complex containing Ubp8S144N. Coloring as in (A).
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Role of Sgf11 in Stabilizing the SAGA DUB ModuleLoop L2 Residue N141 Is Important for Catalysis
The activating S144N and S149N substitutions in Ubp8 both lie
near the asparagine residue, N141 that has been proposed to
stabilize the oxyanion intermediate in USP isopeptidases (Hu
et al., 2002; Zhang et al., 2011). This residue adopts virtually
the identical conformation in the structure of Ubp8 in the intact
DUB module, as well as in structures of the human USP
enzymes, USP8 (Avvakumov et al., 2006) and USP14 (Hu et al.,
2005), (Figure 6A). In the structure of Ubp8 in the intact DUBm,
the backbone amide groups in loop L2 position N141 by
donating four hydrogen bonds to its amide carbonyl (Figure 6A)
thus orienting the amino group of N141 to stabilize the oxyanion
intermediate. To test whether the activating mutations correctly
reconstitute the Ubp8 active site, we compared the effects of
an N141A substitution in both wild-type, intact DUBm and
in DUBm-DSgf11-ZnF-Ubp8S144N/S149N. Assays of K48 diubiqui-
tin cleavage indicate that the N141A substitution has a com-
parable effect in both wild-type and mutant complexes
(Figure 6B). Activity is significantly decreased in both, although
not to the extent of mutation of the active site cysteine, DUBm-
Ubp8C146A, which abrogates activity (Figure 6B). The similar
effects of the Ubp8-N141 substitution on both the wild-
type DUBm and activated deletion mutant, DUBm-DSgf11-Structure 20, 1414ZnF-Ubp8S144N/S149N is consistent with the idea that the N141
side chain is positioned similarly in both complexes. It is thus
likely that N141 forms wild-type backbone interactions with
loop L2 residues 142–145 as seen in the monomeric DUBm (Fig-
ure 6A), suggesting that loop L2 has been stabilized by both
asparagine mutations.
DISCUSSION
There are now a number of examples of deubiquitinating
enzymes that depend upon interactions with partner proteins
for full activity (Cohn et al., 2007, 2009; Kee et al., 2010; Scheuer-
mann et al., 2010; Ventii and Wilkinson, 2008), but the mecha-
nisms by which DUB activity is potentiated has been unclear.
In this study, we sought a structural explanation for the observa-
tion that deletion of the Sgf11-ZnF domain, which binds immedi-
ately adjacent to the Ubp8 active site, significantly disrupts the
activity of the SAGA DUB module. The effect of the Sgf11-ZnF
deletion in our assays is on kcat (Table 1), indicating that Sgf11
plays a role in organizing the active site rather than in promoting
binding of the substrate ubiquitin. We find that the Sgf11-ZnF
domain plays an unexpected role in maintaining the catalytic
activity of Ubp8 by ensuring the proper organization and folding
of the four-protein complex. Our structural and biophysical
studies show that the absence of the Sgf11-ZnF destabilizes
the incorporation of Ubp8 into the DUBm, causing the ZnF-
UBP domain of Ubp8 to peel away from the DUBm and adopt
an extended conformation that promotes domain swapping
and dimerization. The domain swapping arises from a dramatic
change in the conformation of residues 133–145, which are
located in the loop L2 that is contacted by the Sgf11-ZnF in
the intact DUBm. The result of this conformational change is
a displacement of N141, a residue that is important for stabilizing
the oxyanion reaction intermediate. Gain-of-function mutations
S144N, S149N, and S144N/S149N in the active site region of
Ubp8 increased DUBm activity in the absence of the Sgf11-
ZnF. The S149N mutation in particular favors the compact,
monomeric form of the DUBm, whereas the S144N partially
shifts the equilibrium toward the monomer, thus accounting at
least in part for the activating effect of these mutations. The
role of the Sgf11-ZnF in stabilizing the conformation of loop L2,
and thus the active site, provides a potential model for the role
that other proteins, such as UAF1, may play in increasing the
catalytic rate of other USP class deubiquitinating enzymes
(Faesen et al., 2011; Villamil et al., 2012).
Although the observed displacement of the oxyanion residue
N141 is most dramatic in the domain-swapped dimer, destabili-
zation of loop L2 alone would be sufficient to alter the position of
N141 and thus impact catalysis. The concentration of Ubp8 in
yeast, and presumably that of the SAGA DUBm, is 0.1 mM
(Ghaemmaghami et al., 2003), although the effective concentra-
tion of DUBm in the nucleus, and in light of molecular crowding,
is likely significantly higher. Although the proportion of domain-
swapped dimer versus destabilized monomer is thus difficult
to predict, either form of the mutant DUBm would have
decreases catalytic efficiency.
A comparison of Ubp8 to other USP family enzymes shows
that Ubp8 lacks structural features that stabilize the active
conformation of loop L2 in other DUBs. Ubp8 therefore depends–1424, August 8, 2012 ª2012 Elsevier Ltd All rights reserved 1419
Figure 5. Assays of Wild-Type and Mutant DUBm Oligomerization by Velocity Sedimentation
(A) Normalized g(s*) analysis for sedimentation of intact wild-type DUBm. Data are fit to a single Gaussian. Residuals shown below.
(B) Normalized g(s*) analysis for DUBm-DSgf11-ZnF-Ubp8WT. Black dots indicate raw data, which were fit to a sum of two Gaussians (gray) corresponding
to sedimentation of monomeric (red) and dimeric (blue) DUBm.
(C) Analysis as in (B) of DUBm-DSgf11-ZnF-Ubp8S144N.
(D) Analysis as in (B) of DUBm-DSgf11-ZnF-Ubp8S149N.
(E) Analysis as in (B) of DUBm-DSgf11-ZnF-Ubp8S144N/S149N.
(F) Superposition of fitted curves from (A–E); color key in panel inset.
See also Figure S3.
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Role of Sgf11 in Stabilizing the SAGA DUB Moduleupon interactions with the Sgf11-ZnF to stabilize loop L2 and
thereby maintain the enzyme in an active conformation. Mono-
meric USP family DUBs such as USP8 (Avvakumov et al.,
2006) and USP14 (Hu et al., 2005), whose active site residues
are in a catalytically competent configuration in the absence of
substrate, have additional structural features that partly bury
residues in loop L2, further stabilizing its association with the
USP domain. In Ubp8, residues 136–139 are partly solvent-
exposed on the Ubp8 surface, whereas the corresponding resi-
dues are buried in USP8 and USP14 (Figure 7). Burial of these
residues thus stabilizes the association of this strand with the
USP domain, which in turn keeps the oxyanion hole asparagine
residue (N141 in Ubp8) in position for catalysis. In these
enzymes, a protein such as Sgf11 is not required to maintain
the conformation of the L2 loop. In addition, the asparagine cor-
responding to Ubp8 residue S149 forms hydrogen bonds and
van der Waals interactions with loop L2 that favor the position1420 Structure 20, 1414–1424, August 8, 2012 ª2012 Elsevier Ltd Alof the loop seen in the intact, monomeric DUBm (Figure 1E). It
is not clear what features of the USP domain may stabilize this
loop in USP22, the human homolog of yeast Ubp8. Although
USP22 contains an asparagine in place of Ubp8 residue S149,
which is expected to help stabilize loop L2, it may similarly lack
features that bury loop L2 in other USP domains. Although the
lack of sequence conservation in this region of USP domains
makes it difficult to make structural predictions, we speculate
that loop L2 of USP22 similarly depends upon interactions with
the Sgf11 homolog, ATXN7L3, to adopt a catalytically competent
conformation.
The S144N substitution was predicted to hydrogen bond with
loop L1 of Ubp8, which is disordered in the apo DUBm but
contacts both the C-terminal tail of ubiquitin and the Sgf11-
ZnF in the complex with ubiquitin aldehyde (Samara et al.,
2010). This loop is analogous to the ‘‘switching loop’’ of USP7/
HAUSP, which undergoes a substrate-induced conformationall rights reserved
Figure 6. Ubp8-N141 Is Important for DUBm
Catalysis
(A) Superpositions showing hydrogen bonding of
conserved oxyanion hole residue (N141 in Ubp8) to
backbone amides. Apo-Ubp8 (2MHH, gray), hUSP8
(2GFO, pink), and hUSP14 (2AYN, gray).
(B) Effect of Ubp8 active site mutations on DUBm activity
Gel shows time course for cleavage of K48-linked diubi-
quitin for the intact DUBm-WT, DUBm-Ubp8C146A, DUBm-
Ubp8N141A, DUBm-DSgf11-ZnF-Ubp8S144N/S149N, and
DUBm-DSgf11-ZnF-Ubp8S144N/S149N/N141A.
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Role of Sgf11 in Stabilizing the SAGA DUB Modulechange (Hu et al., 2002) and mediates allosteric activation of
HAUSP (Faesen et al., 2011). Loop L1was not, however, ordered
in the structure of the intact DUBm containing the Ubp8-S144N
mutant (Figure S1) or in the domain-swapped dimer (Figure 3B).
It therefore seems unlikely that this loop plays a role in Ubp8
activation analogous to that in USP7 (Faesen et al., 2011).
It remains possible that this residue could form stabilizing inter-
actions within the monomeric form of the DUBm lacking the
Sgf11-ZnF. The modest effect of this mutation on shifting the
equilibrium toward monomeric DUBm lacking the Sgf11-ZnF
as compared to S149N suggests that the S144N substitution
makes a further contribution to activity that remains to be
determined.
Although our studies revealed an unexpected role for Sgf11 in
maintaining the overall folding of the DUBm into a compact
complex, it is possible that the Sgf11-ZnF also contributes to
Ubp8 activity by stabilizing the catalytically competent configu-
ration of the active site through interactions with loops L2. We
were unable to obtain crystals of the monomeric form of the
DUBm lacking the Sgf11-ZnF and containing the Ubp8 S149N
mutation or the S149N/S144N mutations, so this question could
not be addressed directly in our study. The activated double
mutant is still 10-fold less active than the wild-type intact
DUBm, indicating that Sgf11 makes an additional contribution
to full enzymatic activity besides its role in maintaining the prop-
erly folded monomeric DUBm.
The DUBm subunit, Sgf73, may similarly play a dual role in
maintaining the correctly folded conformation of the complex,
as well as contributing in other ways to activation. A portion of
Sgf73, including a zinc finger, lies between the two lobes of the
DUBm, whereas the remainder forms part of the ZnF-UBP
(assembly) lobe. Small deletions of Sgf73 that remove theStructure 20, 1414Sgf73 zinc finger disrupt the incorporation of Sgf73 into the
DUBm and completely abrogate enzymatic activity (Ko¨hler
et al., 2008). Without Sgf73 to hold the two lobes of the DUBm
together, it is possible that the two Ubp8 domains separate via
conformational changes in the linker including loop L2 that joins
the two Ubp8 domains, as has been suggested (Ko¨hler et al.,
2010). This could both transmit conformational changes to the
active site and potentially disrupt the association of the Sgf11-
ZnF as well. Indeed, the Sgf73 zinc finger contacts loop L2
directly (Figure 7A), and could thereby play a role in stabilizing
the compact form of the DUBm. As with Sgf11, the binding of
Sgf73 to the USP domain likely makes further contributions to
enzymatic activity, possibly by affecting the folding of the ubiq-
uitin binding pocket or contributing in other ways to the integrity
of the catalytic domain.
What is the biological advantage of the dependence of Ubp8
activity on its incorporation into the SAGA DUBm, a property
that is shared by the human homolog, USP22 (Ko¨hler et al.,
2010; Lang et al., 2011)? The deubiquitination of H2B-Ub is
tightly regulated during the transcription cycle by the SAGA
complex, which is recruited to the actively transcribed gene
and thus targets Ubp8 to the appropriate location. The depen-
dence of Ubp8 on the other SAGA subunits mitigates against
nonspecific deubiquitination of other substrates, including
poly-ubiquitin chains. In addition to its role in DUBm assembly
that we have demonstrated in this study, Sgf11 is thought to
facilitate interactions with the nucleosome via a cluster of
conserved arginine residues in the Sgf11-ZnF, which form
a basic patch that can interact with the negatively charged
DNA or the conserved acidic patch on H2A-H2B dimers (Bonnet
et al., 2010; Makde et al., 2010; Samara et al., 2010). Similarly,
Sgf73 (Ko¨hler et al., 2008; Lee et al., 2009) and its humanFigure 7. Ubp8 Lacks Conserved Structural
Elements that Could Stabilize Loop L2
(A) View of intact DUBm with transparent surface
depicted for all Ubp8 (green) USP domain residues
except loop L2 in Ubp8 (green). Interactions with
the Sgf11 (orange) and Sgf73 (pink) zinc fingers
help to maintain the observed conformation of
loop L2.
(B) View of USP14 (2AYN, blue) with transparent
surface shown for all residues C-terminal to loop
L2. Additional residues in the USP domain bury
part of loop L2 and form stabilizing b sheet inter-
actions.
(C) View of hUSP8 (2GFO, magenta) with trans-
parent surface shown for all residues excluding
loop L2.
–1424, August 8, 2012 ª2012 Elsevier Ltd All rights reserved 1421
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Role of Sgf11 in Stabilizing the SAGA DUB Modulehomolog ATXN7 (Bonnet et al., 2010) have also been implicated
in binding to nucleosomes, an interaction that is required for
in vivo DUBm activity (Bonnet et al., 2010). Thus, both Sgf11
and Sgf73 have dual roles in coupling activity to substrate recog-
nition and specificity.
The importance of the positioning of loop L2 in Ubp8 is an
‘‘Achilles heel’’ of the USP domain that could be exploited in
drug design. Small molecules that either bind within the loop
L2 binding groove or stabilize the active conformation of loop
L2 could function as inhibitors or activators, respectively.
Because the residues joining helices 214 and 226 of the USP
domain that abut the loop L2 binding groove are not well-
conserved among USP enzymes, these molecules could in prin-
ciple be specific for particular deubiquitinating enzymes, thus
serving as useful tools in cell-based assays and potentially as
therapeutic agents.
EXPERIMENTAL PROCEDURES
Protein Expression and Purification
Rosetta 2(DE3)pLysS (EMD Millipore, Merck KGaA, Darmstadt, Germany)
cells were transformed with three plasmids encoding (1) Ubp8WT, Ubp8S144N,
Ubp8N141A Ubp8S149, Ubp8S144NS149N, or Ubp8S144NS149NN141A (pET-32a, EMD
Millipore), (2) Sus1 (pRSF-1, EMDMillipore), and (3) Sgf11WT or Sgf11DZnF (1-72)
(pCDFDuet-1-MCSI, EMD Millipore), which was cloned into the same vector
as Sgf731-96 (pCDFDuet-1-MCSII, EMD Millipore). All versions of the DUBm
complex were coexpressed and purified using the previously published
protocol for the expression and purification of wild-type DUBm (Samara
et al., 2010).
Protein Crystallization
Crystals were grown by the hanging dropmethod in VDX48 plates with sealant
(Hampton Research, Aliso Viejo, CA). DUBm-DSgf11-ZnF-Ubp8S144N and
DUBm-DSgf11-ZnF-Ubp8WT crystals grew in 14% PEG3350, 0.18–0.22 M
tri-ammonium citrate, and 8%–14% glycerol using a 1:1 ratio of protein/well
solution. Crystals formed within 3 days at 18C and were flash-frozen in liquid
nitrogen in the presence of mother liquor supplemented with 20% glycerol as
a cryo-protectant. The crystals grew to a size of 50 mm 3 500 mm.
Data Collection, Structure Determination, and Refinement
Diffraction data from DUBm-DSgf11-ZnF-Ubp8WT and DUBm-DSgf11-ZnF-
Ubp8S144N crystals were collected at the GM/CA CAT beamline (23ID-B) at
the Advanced Photon Source. Crystals were frozen in cryo-protectants and
stored in pucks that were loaded into a sample exchange robot (ALS/Berkeley
style), and data were collected on aMARMosiac 300 CCD detector. The struc-
ture of each complex was determined by molecular replacement with MolRep
(Vagin and Teplyakov, 1997) using the coordinates of the wild-type DUBm as
the search model (PDB ID: 3MHS). The DUBm-DSgf11-ZnF-Ubp8WT and
DUBm-DSgf11-ZnF-Ubp8S144N structures were refined with PHENIX (Adams
et al., 2002) and Refmac (Murshudov et al., 1997). Coot (Emsley et al., 2010)
was used for manual model building. The DUBm-DSgf11-ZnF-Ubp8WT
complex contains 1307 ordered residues, and the DUBm-DSgf11-ZnF-
Ubp8S144N complex contains 1289 ordered residues out of a total of 1478 in
the crystal and 14 zinc atoms. PyMOL (DeLano, 2002) was used to generate
all structure figures.
K48-Diubiquitin Assays
K48-diubiquitin stock solution was calculated to be 1.45mMby absorbance at
l = 280 nm using an εdi-Ub = 2980 M
1 cm1. Diubiquitin was diluted with
DUBm assay buffer to yield a final reaction concentration of either 40 mM or
100 mM in a reaction volume of 50 mL. A 2.5 ml volume of enzyme at 5.8 mM
(0.5 mg/ml) or 0.58 mM (0.05 mg/ml) was added at 25C, and 47.5 ml of diubi-
quitin was added and mixed by pipetting 10 times. A 10 ml sample was
removed for the 0 min time point that was quenched with 5 ml LDS buffer.
Similar samples were obtained for 30 min, 60 min, and 120 min. A 7.5 ml of1422 Structure 20, 1414–1424, August 8, 2012 ª2012 Elsevier Ltd Aleach sample was loaded into a 4%–12% gradient Bis-Tris NU-PAGE gel
(Invitrogen, Grand Island, NY) for SDS-PAGE, and the gels were stained with
Coomassie Brilliant Blue.
Enzyme Kinetics
Steady-state kinetic measurements were performed using ubiquitin-AMC
dissolved in 100%DMSO (Boston Biochem, Cambridge, MA) as the substrate.
Data were fit to the Michaelis-Menten equation using GraphPad Prism 5
(GraphPad Software). Deubiquitinating (DUB) assays were performed in 384-
well black polystyrene microplates at 30C in a POLARstar Omega plate
reader (BMG Labtech, Cary, NC) using an excitation wavelength of 385 nm
and emission wavelength of 460 nm. DUB reactions were performed in assay
buffer containing 150 mM NaCl, 5 mM DTT, 50 mM HEPES pH 7.6, 25 mM
ZnCl2, and 7.5% DMSO. First, DUBm was titrated into a fixed concentration
of Ub-AMC (2 mM) in order to find a concentration range where initial rate
was independent of enzyme concentration (vi/[Enzyme] = constant; data not
shown). DUBm concentrations were determined spectrophotometrically using
ε280 = 77,240 M
1 cm1. For steady-state kinetic measurements, wild-type
DUBm was held at a concentration of 25 nM, S144N at 25 nM, S149N at
20 nM, DZnF at 400 nM, DZnFS144N at 400 nM, DZnFS149N at 300 nM, and
DZnFS144N/ S149N at 150 nM. Ubiquitin-AMC concentration was varied between
0.23 and 17 mM, which kept the total amount of DMSO below 7.5%. Enzyme
and assay buffer were mixed together in a total reaction volume of 30 mL,
allowed to equilibrate at 30C for 10 min inside the plate reader, and then
Ub-AMC added to initiate the reaction. The release of AMC was followed at
460 nm, and the first 45–300 s of data were used to fit initial rates. In order
to convert intensity units to concentration of Ub-AMC hydrolyzed, the reac-
tions were allowed to incubate for 60 min and the total fluorescence measured
at 30 s intervals for 5 min. When the total fluorescence was invariant with time,
fluorescence versus [Ub-AMC] was plotted to generate a calibration curve.
Sedimentation Velocity Analytical Ultracentrifugation
Sedimentation velocity experiments were performed in an An60Ti rotor at
40,000 rpm at 15C in a Beckman-Coulter XL-I analytical ultracentrifuge.
DUB module samples were dialyzed overnight at 4C into buffer containing
150 mM NaCl, 20 mM HEPES pH 8.0, 5 mM DTT, and 20 mM ZnCl2 and then
loaded into two-sector cells with 12 mm path length and sapphire windows
using the dialysis buffer as the reference. All DUB module constructs were
run at a concentration of 12.9 mM based on an extinction coefficient at
280 nm of 77,240 M1 cm1. Absorbance scans were collected at 280 nm
on 2-min intervals with a 0.003 cm radial step, and a single sample was run
per rotor. Normalized g(s*) data were analyzed using the time-derivative
method implemented in the program DCDT+ version 2.3.2 (Philo, 2006) and
fit either to a single Gaussian or two Gaussians, representing a single or two
sedimenting species, respectively (Stafford, 1997). The same set of scans
was used to analyze each data set. Molecular mass, species concentration,
and sedimentation coefficient were fit for each sedimenting species. The
data were converted to s*(20,w) using protein partial specific volumes and
solvent viscosities calculated from the program SEDNTERP (Laue et al.,
1992). These values, corrected for temperature, were also used for analysis
of sedimentation equilibrium data.
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